Malignant Glioma — Trials

Malignant Glioma — Trials · CancerIndex

Clinical trials

Registered studies

2,053 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 589
Recruiting: 314
Ph III recruiting: 16
Growth YoY: +38.9%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (325)

clinicaltrialsPublishedShowing 201–207 of 207 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00591058	Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma	unknown	Phase 1	36	TransMolecularINDUSTRY	1	Jul 17, 2009	clinicaltrials
NCT00683761	A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma	unknown	Phase 1 / Phase 2	64	TransMolecularINDUSTRY	1	Jul 17, 2009	clinicaltrials
NCT00114309